Sugi Predict

Sugi Predict / Compounds / SCHEMBL1254512

SCHEMBL1254512

SCHEMBL1254512

CN(C)c1ccccc1-c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.45
▸ MAPT P10636 4/20 0.45
▸ MAPK1 P28482 2/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ MEN1 O00255 1/20 0.45
▸ KMT2A Q03164 1/20 0.45
▸ NSD2 O96028 1/20 0.45
▸ EGFR P00533 1/20 0.45
▸ LMNA P02545 1/20 0.45
▸ TDP1 Q9NUW8 1/20 0.45
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ HTR7 P34969 2/20 0.42
▸ HSD17B10 Q99714 2/20 0.42
▸ HPGD P15428 1/20 0.42
▸ BCL2L1 Q07817 1/20 0.42
▸ CYP2A6 P11509 1/20 0.42
▸ PGR P06401 1/20 0.42
▸ TACR1 P25103 2/20 0.41
▸ GAA P10253 2/20 0.41
▸ TP53 P04637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29433183 1.00 ALDH1A1 (0.45) ALDH1A1MAPTMAPK1SMN1; SMN2MEN1
SCHEMBL30763243 0.98 ALDH1A1 (0.44) ALDH1A1MAPTMAPK1SMN1; SMN2MEN1
SCHEMBL27516508 0.98 ALDH1A1 (0.44) ALDH1A1MAPTMAPK1SMN1; SMN2MEN1
SCHEMBL27517786 0.98 ALDH1A1 (0.44) ALDH1A1MAPTMAPK1SMN1; SMN2MEN1
Hydrochloric Acid SCHEMBL2866856 0.98 ALDH1A1 (0.44) ALDH1A1MAPTMAPK1SMN1; SMN2MEN1
SCHEMBL19698852 0.92 MAPT (0.47) ALDH1A1MAPTMAPK1SMN1; SMN2MEN1
Phosphine SCHEMBL27890176 0.89 KCNN4 (0.42) ALDH1A1MAPTMAPK1SMN1; SMN2MEN1
SCHEMBL24703480 0.87 ALDH1A1 (0.40) ALDH1A1MAPTMAPK1SMN1; SMN2MEN1
SCHEMBL18076341 0.86 MAPT (0.47) ALDH1A1MAPTMAPK1SMN1; SMN2MEN1
SCHEMBL6723948 0.85 MEN1 (0.45) ALDH1A1MAPK1SMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 325 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117881670-A Methods of making EGFR inhibitors 缆图药品公司 2024-04-12 — — CN claimed
CN-117467080-B Preparation method of sand-fixing agent 东营煜煌能源技术有限公司 2024-02-27 — — CN claimed
CN-117467080-A Preparation method of sand-fixing agent 东营煜煌能源技术有限公司 2024-01-30 — — CN claimed
CN-116802187-A Organometallic compounds 优米科尔股份公司及两合公司 2023-09-22 — — CN claimed
CN-112062697-B Meta-benzene polyphenol derivative and preparation method thereof 上海特化医药科技有限公司 2023-09-01 — — CN claimed
CN-108242569-B Nonaqueous electrolyte solution and lithium secondary battery 丰田自动车株式会社 2021-01-12 — — CN claimed
CN-111018923-A Carbohydrate monophosphines, process for their preparation and their use 东莞市均成高新材料有限公司 2020-04-17 — — CN claimed
CN-104211559-B A kind of preparation method of tetramethyl biphenyl isomer 哈尔滨工业大学（威海） 2016-08-24 — — CN claimed
WO-2015041879-A1 CATALYST AND PROCESS FOR THE CO-DIMERIZATION OF ETHYLENE AND PROPYLENE EASTMAN CHEMICAL COMPANY (US) 2015-03-26 — — WO claimed
US-20150080628-A1 CATALYST AND PROCESS FOR THE CO-DIMERIZATION OF ETHYLENE AND PROPYLENE EASTMAN CHEMICAL COMPANY (US) 2015-03-19 — — US claimed
CN-102153539-A 3-aminopyrrolidine derivatives as modulators of chemokine receptors INCYTE CORP 2011-08-17 — — CN claimed
US-20100261934-A1 Method for Preparing 2,6-Diethyl-4-Methylphenylacetic Acid BAYER CROPSCIENCE AG (DE) 2010-10-14 — — US claimed
WO-2009051417-A2 PHENANTHRENE LACTAM DERIVATIVES HAVING ANTICANCER ACTIVITY AND METHOD FOR THE PREPARATION THEREOF KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2009-04-23 — — WO claimed
WO-2001092215-A2 SUPEROXIDE-GENERATING DIAZENIUMDIOLATES, COMPOSITIONS COMPRISING SAME, AND METHODS FOR USING SAME US HEALTH (US) 2001-12-06 — — WO claimed
EP-0265135-B1 Antistatic photo-resist MITSUBISHI ELECTRIC CORP (JP) 1993-12-22 — — EP claimed
US-20250230157-A1 AZABENZIMIDAZOLES AND THEIR USE AS AMPA RECEPTOR MODULATORS RAPPORT THERAPEUTICS, INC. 2025-07-17 — — US disclosed
US-20250193977-A1 COMPOSITE LIGHT EMISSION SIGNAL GENERATION MATERIAL FOR STATE SENSING, LIGHT-EMITTING SUBSTANCE CARRIER, INK FOR STATE SENSING, MEASUREMENT CHIP, AND ANALYSIS METHOD Konica Minolta, Inc. (JP) 2025-06-12 — — US disclosed
CN-1075726-A The solidifying agent of resin ZHANG JINPING (CN) 1993-09-01 — — CN disclosed
CN-1070668-A The solidifying agent of tackiness agent JINPING ZHANG (CN) 1993-04-07 — — CN disclosed
US-3969411-A ALCOHOL, PHOSPHORIC ACID BAYER AKTIENGESELLSCHAFT (DT) 1976-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250193977-A1 COMPOSITE LIGHT EMISSION SIGNAL GENERATION MATERIAL FOR STATE SENSING, LIGHT-EMITTING SUBSTANCE CARRIER, INK FOR STATE SENSING, MEASUREMENT CHIP, AND ANALYSIS METHOD ELAVL1, SNRPE, PHAX ALDH1A1 804/4885MAPT 805/4885MAPK1 2752/4885
US-20150080628-A1 CATALYST AND PROCESS FOR THE CO-DIMERIZATION OF ETHYLENE AND PROPYLENE ALOX12, NIT2, NOTUM ALDH1A1 4723/4885MAPT 3661/4885MAPK1 1586/4885
US-20100261934-A1 Method for Preparing 2,6-Diethyl-4-Methylphenylacetic Acid DDT, TET1, DDC ALDH1A1 797/4885MAPT 3985/4885MAPK1 3827/4885
US-20250230157-A1 AZABENZIMIDAZOLES AND THEIR USE AS AMPA RECEPTOR MODULATORS GRIN1, GRIN2B, GRIN3A ALDH1A1 765/4885MAPT 2649/4885MAPK1 2299/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.